Corrigendum: Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate toward tumour blood vessels
Main Authors: | Harada, Hiroshi, Inoue, Masahiro, Itasaka, Satoshi, Hirota, Kiichi, Morinibu, Akiyo, Shinomiya, Kazumi, Zeng, Lihua, Ou, Guangfei, Zhu, Yuxi, Yoshimura, Michio, Mckenna, W. Gillies, Muschel, Ruth J., Hiraoka, Masahiro |
---|---|
Format: | Online |
Language: | English |
Published: |
Nature Pub. Group
2013
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064652/ |
Similar Items
-
Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate towards tumour blood vessels
by: Harada, Hiroshi, et al.
Published: (2012) -
HIF-1-mediated metabolic reprogramming reduces ROS levels and facilitates the metastatic colonization of cancers in lungs
by: Zhao, Tao, et al.
Published: (2014) -
PLK1 blockade enhances therapeutic effects of radiation by inducing cell cycle arrest at the mitotic phase
by: Inoue, Minoru, et al.
Published: (2015) -
UCHL1 provides diagnostic and antimetastatic strategies due to its deubiquitinating effect on HIF-1α
by: Goto, Yoko, et al.
Published: (2015) -
Microenvironment and Radiation Therapy
by: Yoshimura, Michio, et al.
Published: (2013)